Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B

Sensitive and specific enzyme-linked immunosorbent assays were developed to detect Clostridium botulinum neurotoxin serotypes A (BoNT A) and B (BoNT B) in assay buffer and human serum. The assay is based upon affinity-purified horse polyclonal antibodies directed against the similar to 50 kDa C-fragments of each toxin. Standard curves were linear over the range of 0.1-10 ng/mL. Detection was possible at 0.2 ng/mL (20 pg/well) and accurate quantitation at 0.5 ng/mL (50 pg/well) in assay buffer and 10% human serum. Variations between triplicates was typically 5-10%. Less than 1% cross reactivity occurred between other serotypes when each assay was performed against serotypes A, B and E. When tested against toxins complexed to their associated nontoxic proteins, interference was absent (BoNT B) or <25% (BoNT A). These assays demonstrate sensitivity close to that of the mouse bioassay without the use of animals and in a much simpler format than other reported assays of similar sensitivity. Published by Elsevier Science Ltd.